Today

Agents

Chat

Arena

Discover

More

App

PMV Pharmaceuticals Q2 EPS USD -0.34 - PMVP News | Rallies

PMV Pharmaceuticals Q2 EPS USD -0.34

PMVP•2026-08-14

PMV Pharmaceuticals reports second-quarter results

Aug 14 (Reuters) - PMV Pharmaceuticals Q2 operating expenses USD 18.881 million.

Q2 operating income USD -18.881 million
Q2 net income USD -18.086 million

Related News

Zapata Quantum Q2 FY26 net loss widens to $1.84 million; revenue remains no revenue

ZPTA•2026-08-14

Nasdaq Trade Halt <STRRP.O> Halt News Pending at 08:25 AM

STRRP•2026-08-14

US natgas futures edge up on higher demand forecasts

2026-08-14

Climb Bio partner Mabworks doses first patient in China Phase 2 IgA nephropathy trial

CLYM•2026-08-14

Sphere 3D Q2 FY26 operating loss widens to USD 13.82 million; revenue rises 28% to USD 2.5 million vs Q1 FY26

ANY•2026-08-14